Estrella Immunopharma, Inc. (ESLA)

Estrella Immunopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.63	0.92	4.17	2.48	4.09	-
Cash & Short-Term Investments	1.63	0.92	4.17	2.48	4.09	-
Cash Growth	-9.51%	-77.99%	68.02%	-39.36%	-	-
Receivables	-	-	-	0.27	-	-
Prepaid Expenses	0.4	0.72	0.29	-	0.83	-
Total Current Assets	2.02	1.64	4.45	2.75	4.92	-
Long-Term Deferred Charges	-	-	-	0.28	-	-
Other Long-Term Assets	1.5	1.5	-	-	-	-
Total Assets	3.52	3.14	4.45	3.03	4.92	-
Accounts Payable	0.01	0	-	-	-	-
Accrued Expenses	12.96	2.98	0.14	8.85	0.03	-
Current Portion of Leases	0	0	0	0.02	-	-
Current Income Taxes Payable	-	0	0.04	-	-	-
Other Current Liabilities	0.39	0.01	0	0.88	0.92	-
Total Current Liabilities	13.36	3	0.18	9.76	0.95	-
Other Long-Term Liabilities	-	-	-	0.01	0.01	-
Total Liabilities	13.36	3	0.18	9.77	0.96	-
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	27.14	24.64	24.12	0.45	0.03	-
Retained Earnings	-36.38	-23.93	-19.5	-12.19	-1.07	-
Treasury Stock	-0.6	-0.57	-0.35	-	-	-
Total Common Equity	-9.84	0.14	4.27	-11.74	-1.04	-
Shareholders' Equity	-9.84	0.14	4.27	-6.74	3.96	-
Total Liabilities & Equity	3.52	3.14	4.45	3.03	4.92	-
Total Debt	0	0	0	0.02	-	-
Net Cash (Debt)	1.62	0.91	4.16	2.46	4.09	-
Net Cash Growth	-9.53%	-78.06%	69.36%	-39.90%	-	-
Net Cash Per Share	0.04	0.03	0.15	8.04	-	-
Filing Date Shares Outstanding	37.77	36.17	36.19	35.2	0.18	-
Total Common Shares Outstanding	37.77	36.19	36.29	4.06	0.18	-
Working Capital	-11.34	-1.36	4.27	-7.01	3.97	-
Book Value Per Share	-0.26	0.00	0.12	-2.89	-5.91	-
Tangible Book Value	-9.84	0.14	4.27	-11.74	-1.04	-
Tangible Book Value Per Share	-0.26	0.00	0.12	-2.89	-5.91	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q